| Bioactivity | 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil |
| CAS | 2095417-68-6 |
| Formula | C11H17N2O8P |
| Molar Mass | 336.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil
CAS: 2095417-68-6 F: C11H17N2O8P W: 336.24
1-uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymph
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.